Merck Life Science arm, Department of Atomic Energy collaborate for heavy water supply

AK Mohanty, secretary of DAE and chairman of the Atomic Energy Commission, said local production of DLCs by private parties will boost exports from India.

Published On 2023-05-21 09:00 GMT   |   Update On 2023-05-21 09:00 GMT

Mumbai: The Department of Atomic Energy on Thursday tied up with pharma company Merck Life Science to supply heavy water for five years.The agreement between Heavy DAE's Heavy Water Board and Merck's sister concern Sigma Aldrich Chemicals will enable the production of deuterium labelled compounds (DLCs) and allied value-added products, as per an official statement.AK Mohanty, secretary of DAE...

Login or Register to read the full article

Mumbai: The Department of Atomic Energy on Thursday tied up with pharma company Merck Life Science to supply heavy water for five years.

The agreement between Heavy DAE's Heavy Water Board and Merck's sister concern Sigma Aldrich Chemicals will enable the production of deuterium labelled compounds (DLCs) and allied value-added products, as per an official statement.
AK Mohanty, secretary of DAE and chairman of the Atomic Energy Commission, said local production of DLCs by private parties will boost exports from India.
"Investment in India for manufacturing of deuterated products will benefit the country with respect to the growth of local chemicals and pharmaceutical sectors, thus increasing the supply of high-value products," he said.
The agreement was signed between HWB's director for operation VVSA Prasad and Merck's managing director Sreenath Narayanaiah at DAE's office in south Mumbai in the presence of Mohanty, DAE's additional secretary A R Sule, HWB chairman and chief executive J Srivastava, the statement said.
Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News